Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Obstet Gynaecol ; 35(8): 844-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26156575

RESUMO

The aim of this study was to investigate the effect of clarithromycin in rat endometriosis and its association with matrix metalloproteinase-9 (MMP-9) expression. After surgical induction of endometriosis, 27 rats were randomised into three groups. Size of endometriotic implants were evalutated and rats in group I (n = 9) were given 100 mg/kg/day of oral clarithromycin, rats in group II (n = 9) were given single 1 mg/kg s.c. injection of leuprolide acetate and rats in group III (n = 9) were not given any medication for 21 days. At the end of 21 days of medication, remaining 23 rats were sacrificed to evaluate morphological and histological features of implants. There was a significant difference between the groups in implant volumes (p = 0.004) before and after medication. Regression of implants were significantly higher in groups I and II than that in control group (p = 0.009 and p = 0.011, respectively). After medication, in group I the implant volume decreased from 62 (12-166) mm(3) to 26 (3-87) mm(3) (p = 0.012) and in group II the volume decreased from 224 (76-1135) mm(3) to 62 (26-101) mm(3) (p = 0.028). There was a significant difference between groups in histopathological score (p = 0.024). The epithelial immunohistochemical score of MMP-9 was significantly lower in group II than that in control group (p = 0.014). In conclusion, clarithromycin regresses endometriotic implants in rats, but not via MMP-9.


Assuntos
Claritromicina/uso terapêutico , Endometriose/tratamento farmacológico , Inibidores da Síntese de Proteínas/uso terapêutico , Animais , Claritromicina/farmacologia , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Endometriose/enzimologia , Feminino , Metaloproteinase 9 da Matriz/metabolismo , Inibidores da Síntese de Proteínas/farmacologia , Distribuição Aleatória , Ratos Wistar
2.
Epidemiol Infect ; 143(4): 720-4, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24877882

RESUMO

Since measles is a highly contagious respiratory infection with significant airborne transmission risk in hospitals, effective prevention measures are crucial. After a mother accompanying her child on a paediatric ward lacking a negative pressure room was diagnosed with measles, exposed persons without evidence of immunity (documentary evidence of receiving two doses of measles-mumps-rubella vaccine) were treated with vaccination or intravenous immunoglobulin (IVIG). The interruption of transmission with these treatments was evaluated. There were 44 children and 101 adults exposed to the index patient. Twenty-five children and 88 adults were considered immune, providing evidence of immunity. Nineteen children and 13 adults were either given vaccination or IVIG for post-exposure prophylaxis (PEP). There were no additional cases of measles after 3 weeks follow-up. We conclude that measles is highly preventable by adequate PEP with vaccination or IVIG in a healthcare setting that lacks the benefit of a negative pressure room.


Assuntos
Infecção Hospitalar/prevenção & controle , Sarampo/prevenção & controle , Adolescente , Criança , Pré-Escolar , Feminino , Hospitais Universitários , Humanos , Imunoglobulinas/uso terapêutico , Lactente , Masculino , Vacina contra Sarampo/uso terapêutico , Pessoa de Meia-Idade , Profilaxia Pós-Exposição/métodos , Turquia/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA